Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s40261-021-01048-z | DOI Listing |
Publication Analysis
Top Keywords
blister-packing buprenorphine
4
buprenorphine monoproduct
4
monoproduct patient-centered
4
patient-centered method
4
method microdosing
4
microdosing buprenorphine
4
buprenorphine induction
4
blister-packing
1
monoproduct
1
patient-centered
1
Similar Publications
Enhancing Outcomes in Opioid Use Disorder Treatment: An Economic Evaluation of Improving Medication Adherence for Buprenorphine Through Blister-Packaging.
Subst Abuse Rehabil
October 2024
Health Economics & Outcomes Research; Becton, Dickinson and Company, Franklin Lakes, NJ, USA.
Background: The opioid epidemic has severely impacted the US over the last 15 years. Buprenorphine is a partial opioid agonist indicated for the treatment of opioid use disorder (OUD) and is recognized as an effective treatment when taken as prescribed. However, adherence rates have been low in real-world settings.
View Article and Find Full Text PDFBlister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction.
Clin Drug Investig
July 2021
Sunset Terrace Family Health Center at NYU Brooklyn, 514 49th Street, Brooklyn, NY, 11220, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!